Case report demonstrates disease-free survival following neoadjuvant chemotherapy and surgery in metastatic epithelioid trophoblastic tumour, highlighting the benefit of multidisciplinary care.
Epithelioid trophoblastic tumour (ETT) is a rare form of gestational trophoblastic disease (GTD).We report a case of a 28-year-old woman presenting with abnormal uterine bleeding and mildly elevated serum beta human chorionic gonadotropin (β-hCG) levels.Imaging revealed a heterogeneous uterine mass with lymphadenopathy and pulmonary metastases.Core biopsy histology suggested ETT, but definitive subclassification was limited by small sample size and an ambiguous immunohistochemical profile, which is itself a recognised source of diagnostic uncertainty in this entity.The patient received neoadjuvant platinum-based chemotherapy, followed by total hysterectomy with bilateral salpingo-oophorectomy and lymphadenectomy.At 10 months postoperatively, the patient remains disease-free with normalisation of β-hCG levels.This case illustrates the diagnostic challenges inherent to GTD, particularly the overlap between ETT, placental site trophoblastic tumour (PSTT) and choriocarcinoma; emphasises the importance of integrating multimodal imaging with histopathology within a multidisciplinary team; and demonstrates that a combined approach of chemotherapy and surgical resection can lead to favourable outcomes in this rare entity.
No takes yet. Share an insight, caveat, or question.
Carvalho et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: